1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Insulin Delivery Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Insulin Delivery Market, Asia-Pacific
3.1 Insulin Delivery Market, Asia-Pacific, Revenue ($m), 2018-2033
3.2 Insulin Delivery Market, Asia-Pacific, Revenue ($m), 2018-2033
3.3 Insulin Delivery Market, Asia-Pacific, Volume (Units), 2018-2033
3.4 Insulin Delivery Market, Asia-Pacific, Volume (Units), 2018-2033
3.5 Insulin Delivery Market, Asia-Pacific, Company Share by Revenue ($m), 2025
4 Insulin Delivery Market, Australia
4.1 Insulin Delivery Market, Australia, Revenue ($m), 2018-2033
4.1.1 Insulin Pens Market, Australia, Revenue ($m), by Segment, 2018-2033
4.1.2 Insulin Pumps Market, Australia, Revenue ($m), by Segment, 2018-2033
4.2 Insulin Delivery Market, Australia, Volume (Units), 2018-2033
4.2.1 Insulin Pens Market, Australia, Volume (Units), by Segment, 2018-2033
4.2.2 Insulin Pumps Market, Australia, Volume (Units), by Segment, 2018-2033
4.3 Insulin Delivery Market, Australia, Average Price ($), 2018-2033
4.4 Insulin Delivery Market, Australia, Company Share by Revenue ($m), 2025
5 Insulin Delivery Market, China
5.1 Insulin Delivery Market, China, Revenue ($m), 2018-2033
5.1.1 Insulin Pens Market, China, Revenue ($m), by Segment, 2018-2033
5.1.2 Insulin Pumps Market, China, Revenue ($m), by Segment, 2018-2033
5.2 Insulin Delivery Market, China, Volume (Units), 2018-2033
5.2.1 Insulin Pens Market, China, Volume (Units), by Segment, 2018-2033
5.2.2 Insulin Pumps Market, China, Volume (Units), by Segment, 2018-2033
5.3 Insulin Delivery Market, China, Average Price ($), 2018-2033
5.4 Insulin Delivery Market, China, Company Share by Revenue ($m), 2025
6 Insulin Delivery Market, India
6.1 Insulin Delivery Market, India, Revenue ($m), 2018-2033
6.1.1 Insulin Pens Market, India, Revenue ($m), by Segment, 2018-2033
6.1.2 Insulin Pumps Market, India, Revenue ($m), by Segment, 2018-2033
6.2 Insulin Delivery Market, India, Volume (Units), 2018-2033
6.2.1 Insulin Pens Market, India, Volume (Units), by Segment, 2018-2033
6.2.2 Insulin Pumps Market, India, Volume (Units), by Segment, 2018-2033
6.3 Insulin Delivery Market, India, Average Price ($), 2018-2033
6.4 Insulin Delivery Market, India, Company Share by Revenue ($m), 2025
7 Insulin Delivery Market, Japan
7.1 Insulin Delivery Market, Japan, Revenue ($m), 2018-2033
7.1.1 Insulin Pens Market, Japan, Revenue ($m), by Segment, 2018-2033
7.1.2 Insulin Pumps Market, Japan, Revenue ($m), by Segment, 2018-2033
7.2 Insulin Delivery Market, Japan, Volume (Units), 2018-2033
7.2.1 Insulin Pens Market, Japan, Volume (Units), by Segment, 2018-2033
7.2.2 Insulin Pumps Market, Japan, Volume (Units), by Segment, 2018-2033
7.3 Insulin Delivery Market, Japan, Average Price ($), 2018-2033
7.4 Insulin Delivery Market, Japan, Company Share by Revenue ($m), 2025
8 Insulin Delivery Market, South Korea
8.1 Insulin Delivery Market, South Korea, Revenue ($m), 2018-2033
8.1.1 Insulin Pens Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.2 Insulin Pumps Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.2 Insulin Delivery Market, South Korea, Volume (Units), 2018-2033
8.2.1 Insulin Pens Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.2 Insulin Pumps Market, South Korea, Volume (Units), by Segment, 2018-2033
8.3 Insulin Delivery Market, South Korea, Average Price ($), 2018-2033
8.4 Insulin Delivery Market, South Korea, Company Share by Revenue ($m), 2025
9 Overview of Key Companies in Asia-Pacific Insulin Delivery Market
9.1 Novo Nordisk AS
9.1.1 Company Overview
9.2 Sanofi
9.2.1 Company Overview
9.3 Eli Lilly and Co
9.3.1 Company Overview
9.4 Medtronic Plc
9.4.1 Company Overview
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company Overview
10 Insulin Delivery Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 Nov 03, 2025: CUHK Launches Four-Year DNA Testing Programme to Screen 9,000 Adults for Young-Onset Diabetes Risk
11.1.2 Oct 16, 2025: Gan & Lee Pharmaceuticals Appoints Dr. Ting Jia as Corporate VP and CMO
11.2 Financial Announcements
11.2.1 Aug 07, 2025: Lilly Announces Q2 2025 Results and Raises Guidance
11.2.2 Aug 07, 2025: Insulet Reports Second Quarter 2025 Revenue Increase of
32.9% Year-Over-Year (31.3% Constant Currency)
11.3 Government and Public Interest
11.3.1 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD
11.3.2 Sep 18, 2025: Sydney Excellence Awards Highlights
11.4 Other Significant Developments
11.4.1 Nov 03, 2025: CUHK Launches Four-Year DNA Testing Programme to Screen 9,000 Adults for Young-Onset Diabetes Risk
11.5 Product News
11.5.1 Nov 22, 2025: Insul-eze Syringe Magnifier 2x Magnification for Easy Viewing
11.5.2 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes
11.5.3 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation
11.5.4 Nov 03, 2025: Sandstone Easydrip Plus with Hextra Tech Hexagonal Broad Hub Enhances Insulin Injection Comfort
11.5.5 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment
11.5.6 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
11.5.7 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes
11.5.8 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD
11.5.9 Sep 08, 2025: Hyosung’s Smart Insulin Pen, Diacon P8, Has Been Proven Effective in Improving Blood Sugar Levels in Clinical Studies
11.5.10 Dec 26, 2024: Researchers at IIT Bombay Develop a Shockwave-Based Needle-Free Syringe that Ensures Painless and Safe Drug Delivery with Lesser Damage to Skin and Lower Risk of Infection
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Market Modeling and Forecasting
12.1.5 Company Share Analysis
12.1.6 Benchmarking
12.2 GlobalData Consulting
12.3 Contact Us
12.4 Disclaimer